PURPOSE To report the effects of combined onabotulinumtoxinA (Botox) injections and myofascial release physical therapy on myofascial pelvic pain (MFPP) by comparing pre- and posttreatment average pelvic pain scores, trigger points, and patient self-reported pelvic pain. Secondary outcomes were to examine posttreatment complications and determine demographic differences between patients with/wi...

Do different formulations of botulinum toxin type A really have different migration characteristics? The dose units of the two main botulinum toxin A products are not equivalent, and there is continuing controversy about the appropriate dose conversion ratio. Cliff et al . 1 report on a study of anhidrotic halos after injections of Dysport and Botox to the forehead at a dose ratio of 3 : 1. The...

BACKGROUND There are several commercially available neurotoxins to improve facial aesthetics, but few prospective, randomized trials have been conducted without commercial support to compare these agents. OBJECTIVES The authors present the results of a study examining and comparing the effects of onabotulinumtoxinA (BoNT-ONA; Botox, Allergan, Inc., Irvine, California) and abobotulinumtoxinA (...

The author uses combination volume rejuvenation therapy (CVRT) in patients who desire facial rejuvenation with minimal downtime. He describes how the combined use of relatively large doses of multiple injectables-including fat, pharmaceutical soft tissue fillers, and Botox-permits simultaneous volume rejuvenation of most facial areas with or without excisional surgery.

For the past six years, we have been teaching a neuroscience for non-science majors course titled "From Botox to Behavior: Neuroscience for non-scientists." The primary objectives for this course are to create science literate students using neuroscience concepts as the foundation. The evidence from our course assessments suggest that the students are learning fundamental concepts and developin...